Total Payments
$644.42
2023 Payments
$130.17
Companies
10
Transactions
25
Medicare Patients
2,665
Medicare Billing
$652,598
Payment Breakdown by Category
Food & Beverage$632.73 (98.2%)
Education$11.69 (1.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $632.73 | 24 | 98.2% |
| Education | $11.69 | 1 | 1.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AbbVie Inc. | $197.12 | 14 | $0 (2021) |
| Boston Scientific Corporation | $155.30 | 2 | $0 (2020) |
| NESTLE HEALTHCARE NUTRITION INC. | $130.17 | 1 | $0 (2023) |
| Olympus America Inc. | $70.27 | 1 | $0 (2019) |
| PFIZER INC. | $22.08 | 2 | $0 (2017) |
| Gilead Sciences, Inc. | $19.32 | 1 | $0 (2020) |
| Ferring Pharmaceuticals Inc. | $16.06 | 1 | $0 (2022) |
| GlaxoSmithKline, LLC. | $12.82 | 1 | $0 (2018) |
| Janssen Pharmaceuticals, Inc | $11.69 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $130.17 | 1 | NESTLE HEALTHCARE NUTRITION INC. ($130.17) |
| 2022 | $16.06 | 1 | Ferring Pharmaceuticals Inc. ($16.06) |
| 2021 | $72.88 | 5 | AbbVie Inc. ($72.88) |
| 2020 | $146.39 | 6 | Boston Scientific Corporation ($74.98) |
| 2019 | $175.94 | 4 | Boston Scientific Corporation ($80.32) |
| 2018 | $57.73 | 4 | AbbVie, Inc. ($35.32) |
| 2017 | $45.25 | 4 | AbbVie, Inc. ($23.17) |
All Payment Transactions
25 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/09/2023 | NESTLE HEALTHCARE NUTRITION INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $130.17 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 03/09/2022 | Ferring Pharmaceuticals Inc. | CIMZIA (Drug) | Food and Beverage | In-kind items and services | $16.06 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/26/2021 | AbbVie Inc. | CREON (Drug) | Food and Beverage | In-kind items and services | $14.03 | General |
| Category: ENDOCRINOLOGY | ||||||
| 09/27/2021 | AbbVie Inc. | CREON (Drug), VIBERZI, LINZESS | Food and Beverage | In-kind items and services | $16.81 | General |
| Category: ENDOCRINOLOGY | ||||||
| 08/30/2021 | AbbVie Inc. | CREON (Drug) | Food and Beverage | In-kind items and services | $14.11 | General |
| Category: ENDOCRINOLOGY | ||||||
| 04/28/2021 | AbbVie Inc. | CREON (Drug) | Food and Beverage | In-kind items and services | $13.98 | General |
| Category: ENDOCRINOLOGY | ||||||
| 03/22/2021 | AbbVie Inc. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $13.95 | General |
| Category: IMMUNOLOGY | ||||||
| 09/14/2020 | AbbVie Inc. | CREON (Drug) | Food and Beverage | In-kind items and services | $14.32 | General |
| Category: ENDOCRINOLOGY | ||||||
| 09/09/2020 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $19.32 | General |
| 06/15/2020 | AbbVie Inc. | CREON (Drug) | Food and Beverage | In-kind items and services | $11.37 | General |
| Category: ENDOCRINOLOGY | ||||||
| 02/26/2020 | Janssen Pharmaceuticals, Inc | — | Education | In-kind items and services | $11.69 | General |
| 02/12/2020 | AbbVie Inc. | CREON (Drug) | Food and Beverage | In-kind items and services | $14.71 | General |
| Category: ENDOCRINOLOGY | ||||||
| 01/08/2020 | Boston Scientific Corporation | CAPTIVATOR COLD (Device) | Food and Beverage | In-kind items and services | $74.98 | General |
| Category: POLYPECTOMY | ||||||
| 08/26/2019 | AbbVie, Inc. | Creon (Drug) | Food and Beverage | In-kind items and services | $11.61 | General |
| Category: Endocrinology | ||||||
| 04/03/2019 | AbbVie, Inc. | Creon (Drug) | Food and Beverage | In-kind items and services | $13.74 | General |
| Category: Endocrinology | ||||||
| 03/28/2019 | Boston Scientific Corporation | SPYGLASS (Device) | Food and Beverage | In-kind items and services | $80.32 | General |
| Category: BILIARY DEVICES | ||||||
| 02/13/2019 | Olympus America Inc. | EVIS EXERA (Device) | Food and Beverage | In-kind items and services | $70.27 | General |
| Category: GI & Respiratory Products | ||||||
| 11/15/2018 | Takeda Pharmaceuticals U.S.A., Inc. | Amitiza (Drug) | Food and Beverage | In-kind items and services | $9.59 | General |
| Category: Lower GI | ||||||
| 09/24/2018 | AbbVie, Inc. | Creon (Drug) | Food and Beverage | In-kind items and services | $21.28 | General |
| Category: Endocrinology | ||||||
| 08/29/2018 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), BOOSTRIX, FLUARIX | Food and Beverage | In-kind items and services | $12.82 | General |
| Category: VACCINES | ||||||
| 07/09/2018 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $14.04 | General |
| Category: Immunology | ||||||
| 12/04/2017 | PFIZER INC. | INFLECTRA (Biological) | Food and Beverage | In-kind items and services | $11.34 | General |
| Category: INFLAMMATION | ||||||
| 08/07/2017 | AbbVie, Inc. | Mavyret (Drug) | Food and Beverage | In-kind items and services | $10.54 | General |
| Category: Virology | ||||||
| 05/26/2017 | PFIZER INC. | INFLECTRA (Biological) | Food and Beverage | In-kind items and services | $10.74 | General |
| Category: INFLAMMATION | ||||||
| 03/27/2017 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $12.63 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 4 | 63 | 63 | $29,500 | $4,325 |
| 2021 | 20 | 1,335 | 14,038 | $1.7M | $375,338 |
| 2020 | 21 | 1,267 | 8,842 | $1.2M | $272,935 |
Total Patients
2,665
Total Services
22,943
Medicare Billing
$652,598
Procedure Codes
45
All Medicare Procedures & Services
45 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 15 | 15 | $20,460 | $2,859 | 14.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 15 | 15 | $4,200 | $872.71 | 20.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 11 | 11 | $2,090 | $501.83 | 24.0% |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Facility | 2022 | 22 | 22 | $2,750 | $90.86 | 3.3% |
| J3380 | Injection, vedolizumab, 1 mg | Office | 2021 | 21 | 9,900 | $376,200 | $165,650 | 44.0% |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | Office | 2021 | 31 | 2,711 | $441,893 | $88,671 | 20.1% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 230 | 230 | $313,720 | $43,954 | 14.0% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2021 | 83 | 83 | $94,620 | $14,352 | 15.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 79 | 92 | $25,760 | $8,639 | 33.5% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Facility | 2021 | 82 | 82 | $99,958 | $7,119 | 7.1% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 41 | 41 | $21,443 | $6,229 | 29.0% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 47 | 47 | $20,163 | $5,983 | 29.7% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 83 | 84 | $84,756 | $5,741 | 6.8% |
| 96413 | Infusion of chemotherapy into a vein up to 1 hour | Office | 2021 | 31 | 51 | $18,207 | $5,457 | 30.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 42 | 69 | $12,006 | $3,739 | 31.1% |
| 43248 | Insertion of guide wire with dilation of esophagus using an endoscope | Facility | 2021 | 31 | 33 | $34,320 | $3,448 | 10.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 49 | 51 | $9,690 | $3,413 | 35.2% |
| 43235 | Diagnostic examination of esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 40 | 40 | $29,520 | $3,044 | 10.3% |
| 91065 | Measurement of hydrogen in breath to test for gi symptoms | Office | 2021 | 19 | 41 | $10,536 | $2,845 | 27.0% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour | Office | 2021 | 24 | 39 | $7,332 | $2,102 | 28.7% |
| 45378 | Diagnostic examination of the colon (large bowel) using an endoscope(colonoscopy); high risk | Facility | 2021 | 15 | 15 | $17,100 | $2,018 | 11.8% |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Facility | 2021 | 339 | 350 | $43,750 | $1,472 | 3.4% |
| 96415 | Infusion of chemotherapy into a vein | Office | 2021 | 31 | 51 | $7,038 | $1,172 | 16.6% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 17 | 28 | $1,680 | $290.79 | 17.3% |
| J3380 | Injection, vedolizumab, 1 mg | Office | 2020 | 15 | 6,000 | $206,400 | $96,924 | 47.0% |
About Dr. Gary Varilek, MD
Dr. Gary Varilek, MD is a Specialist healthcare provider based in Lincoln, Nebraska. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/02/2005. The National Provider Identifier (NPI) number assigned to this provider is 1104810209.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gary Varilek, MD has received a total of $644.42 in payments from pharmaceutical and medical device companies, with $130.17 received in 2023. These payments were reported across 25 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($632.73).
As a Medicare-enrolled provider, Varilek has provided services to 2,665 Medicare beneficiaries, totaling 22,943 services with total Medicare billing of $652,598. Data is available for 3 years (2020–2022), covering 45 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Other Specialties Gastroenterology
- Location Lincoln, NE
- Active Since 09/02/2005
- Last Updated 02/19/2018
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1104810209
Products in Payments
- ZENPEP (Drug) $130.17
- CREON (Drug) $99.33
- SPYGLASS (Device) $80.32
- CAPTIVATOR COLD (Device) $74.98
- EVIS EXERA (Device) $70.27
- Creon (Drug) $46.63
- Humira (Biological) $26.67
- INFLECTRA (Biological) $22.08
- CIMZIA (Drug) $16.06
- HUMIRA (Biological) $13.95
- SHINGRIX (Biological) $12.82
- Mavyret (Drug) $10.54
- Amitiza (Drug) $9.59
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Lincoln
David Samani, M.d, M.D
Specialist — Payments: $21,983
Specialist $21,983
Dr. Joseph Camarata, M.d., D.m.d, M.D., D.M.D
Specialist — Payments: $14,221
Specialist $14,221
Dr. Mark Griffin, Md, MD
Specialist — Payments: $8,119
Specialist $8,119
Dr. Kirk Kinberg, M.d, M.D
Specialist — Payments: $4,438
Specialist $4,438
Dr. Clark Antonson, Md, MD
Specialist — Payments: $4,344
Specialist $4,344
Dr. Matthew Hrnicek, Md, MD
Specialist — Payments: $4,123
Specialist $4,123